Qianjiang Yongan Pharmaceutical Co., Ltd.
SHZ: 002365.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Rengui Hong
- Employees
- 930
- Headquarters
- Qianjiang, China
- IPO year
- 2010
- Market cap
- CN¥4.1B
- Website
- https://www.chinataurine.com
Loading 002365…
Loading profile data…Frequently asked questions about 002365
What does Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) do?
Qianjiang Yongan Pharmaceutical Co., Ltd. manufactures and sells taurine in China. The company was founded in 2001 and is based in Qianjiang, China.
Where does 002365.SZ trade?
Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002365.SZ in?
Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Qianjiang Yongan Pharmaceutical Co., Ltd.?
Rengui Hong is the chief executive officer of Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ).
Where is Qianjiang Yongan Pharmaceutical Co., Ltd. headquartered?
Qianjiang Yongan Pharmaceutical Co., Ltd. is headquartered in China.
Does 002365.SZ pay a dividend?
Yes — Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) paid a trailing twelve-month dividend of CNY 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002365.SZ go public?
Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) completed its initial public offering in 2010.